Remote and In-Home Monitoring Tech for Maternity Care Expands
Recent media highlights a growing trend of leveraging digital tools to improve maternal outcomes. Technologies for online and in-home monitoring are being used to track maternal vital signs, fetal movement, and contractions, aiming to facilitate earlier identification of complications. This trend is demonstrated in platforms designed for remote patient support and in-home contraction monitoring systems.
- The U.S. Food and Drug Administration (FDA) has been actively clearing new in-home monitoring technologies, such as the Bloomlife MFM-Pro, a prescription-based wearable to track maternal and fetal heart rates, and the INVU sensor band by Nuvo Group for third-trimester fetal health monitoring. The COVID-19 pandemic accelerated this trend by prompting the FDA to issue guidance expanding the availability of non-invasive fetal and maternal monitoring devices for home use. - Several companies are prominent in developing these technologies, including Babyscripts, which offers a virtual care platform for obstetrics, and Nuvo Group, which partners with health systems like Philips to increase access to remote fetal monitoring in rural areas. Other innovators include Bloomlife, which transitioned from a consumer pregnancy tracker to a medical device company. - Research indicates that remote patient monitoring can lead to better health outcomes, with one study showing it can reduce hospital admissions for pregnancy-related hypertension by up to 30%. Studies are also exploring how engagement with these technologies may improve the detection of conditions like preeclampsia. - The use of telehealth in obstetrics has increased significantly, from just 0.1% of pregnancy-related claims pre-pandemic to now accounting for 13-17% of all office and outpatient visits across specialties. This shift is seen as a way to improve access to care, especially in rural areas where the risk of severe maternal morbidity or mortality is 9% higher than in urban areas. - In Virginia, recent legislation (HB 1976) has directed Medicaid to clarify coverage for remote patient monitoring for high-risk pregnancies, including conditions like maternal diabetes and hypertension. Additionally, Virginia law does not require healthcare providers offering services exclusively through telemedicine to have a physical presence in the state to be eligible for Medicaid enrollment. - Remote monitoring is also being leveraged to address racial disparities in maternal health. Studies have shown that telehealth can reduce racial disparities in postpartum follow-up for hypertensive disorders of pregnancy and was associated with decreased racial disparities in postpartum visit attendance during the COVID-19 pandemic. - The integration of Artificial Intelligence (AI) is a key trend, with AI-powered mobile apps providing personalized guidance and predictive analytics being used to assess the risk of complications. These technologies can analyze a patient's medical history and real-time data to offer tailored support. - Professional organizations like the American College of Obstetricians and Gynecologists (ACOG) have established task forces to coordinate and facilitate the use of telehealth to improve maternal morbidity and mortality. This includes using remote technology for consultations in maternal-fetal medicine, managing conditions like gestational diabetes, and providing genetic counseling.
